维普中文期刊产品整合服务
119篇 您的检索式:作者名="Haperen"
    题名 作者 年代 出处 被引量
1Interaction between cisplatin and gemcitabine in vitro and in vivo 显示文摘Peters G J Bergman A M Ruiz van Haperen V W 1995Semin Oncol1995,22,411:1
2Randomized phase II comparison of dose-intense gem-citabine:thirty-minute infusion and fixed dose rate in-fusion in patients with pancreatic adenocarcinoma显示文摘Tempero M Plunkett W Ruiz Van Haperen V 2003JClin Oncol2003,21,34:1
3Synergistic interaction between ciaplatin and gemcitabine in vitro 显示文摘Bergman A M Ruiz van Haperen V W Veerman G 1996Clin Cancer Res1996,2,3:1
4Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress 显示文摘Cheng C Tempel D van Haperen R 2006Circulation2006,113,:1
5Increased risk of atherosclerosis by elevated plasma levels of phospholipid transfer protein显示文摘VAN HAPEREN R VAN TOL A VAN GENT T 2002J Biol Chem2002,277,48:1
6IL-7 and IL-15 bypass the immunosuppressive action of anti-CD25 monoclonal antibodies显示文摘Basn CC Boelaars-van Haperen MJ Van Riemsdijk IC 2001Transplant Proc2001,33,3:1
7Randomized pahse 2 comparison of dose-intense gemcitabine: thirty-minute infusion and fixed dose rate infusion in patients with pancreatic adenocarcinoma显示文摘Tempero M Plunkett W Ruiz Van Haperen V 2003J clin oncol2003,21,18:1
8Activation of MMP8 and MMP13 by angiotensin Ⅱ correlates to severe intra-plaque hemorrhages and collagen breakdown in athero- sclerotic lesions with a vulnerable phenotype显示文摘Cheng C Tempel D van Haperen R 2009Athero- sclerosis2009,204,1:1
9Development and molecularcharacterization of a 2',2'-difluorodeoxycytidine-resistant variant of the human ovariancarcinoma cell line A2780显示文摘Ruiz van Haperen VW Veerman G Eriksson S 1994Cancer Res1994,54,:1
10Shear stress affects the intracellular distribution of eNOS : direct demonstration by a novel in vivo technique 显示文摘Cheng C van Haperen R de Waard M 2005Blood2005,106,12:1
11Antitumor activity of prolonged as compared with bolus administration of 2' ,2' - difluorodexycytidine in vivo against murine colon tumors cancer显示文摘Veerman G Ruiz Haperen Vermorken JB Chemother Pharmacol0,38,4:1
12Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress显示文摘Cheng C Tempel D van Haperen R 2006Circulation2006,113,23:1
13Atheroselerotic lesion size and vulnerability are determined by patterns of fluid shear stress显示文摘Cheng C Tempel D van Haperen R 2006Circulation2006,113,:1
14R-N-(Pentafluoroben- zoyl)phenylglycine as a chiral stationary phase for the separa- tion of enantiomers by high-performance liquid chromatogra- phy 显示文摘Kip J Haperen P V Kraak J C 1986Journal of Chromatography A1986,356,:1
15Angiogenic murine endothelial progenitor cells are derived from a myeloid bone marrow fraction and can be identified by endothelial NO synthase expression 显示文摘Kranzho C J Wan H de Crom R van Haperen R de Boer HC Leenen PJ Drexhage HA Rabelink TJ van Zonneveld A J Staal FJ 2006Arterioscler Thromb Vasc Biol2006,26,:1
16Atherosclerotic lesion size and vulnerability are determined by patterns of fluid shear stress 显示文摘Cheng C Tempel D van Haperen R 2006Circulation2006,113,23:1
17Beneficial ef- fects of exercise training after myocardial infarction require full eNOS expression显示文摘WAARD M C HAPEREN R SOULLIE T 2010Journal of Molecular and Cellular Cardiolo- gy2010,48,6:1
18Shear stress affects the intracellular distribution of eNOS: direct demonstration by a novel in vivo technique 显示文摘Cheng C van Haperen R de Waard M 2005Blood2005,106,12:1
19In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit MI as a major determinant 显示文摘Bergman A M Eijk P P Ruiz van Haperen V W 2005Cancer Res2005,65,20:1
20In vi- vo induction of resistance to gemcitabine results in in- creased expression of ribonucleotide reductase subunit M1 as the major determinant 显示文摘Bergman AM Eijk PP Ruiz van Haperen VW 2005Cancer Res2005,65,20:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费